Sign Up to like & get
recommendations!
1
Published in 2018 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17274
Abstract: DEAR EDITOR, We thank two of the authors of LIBERTY AD CHRONOS for replying to our critical appraisal. We felt that our appraisal was a fair, independent and balanced critical assessment of the study, whereby…
read more here.
Keywords:
smartphone app;
study;
review british;
patients moderate ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Dermatology"
DOI: 10.1111/bjd.21880
Abstract: Brepocitinib (PF-06700841) is a small-molecule dual inhibitor of tyrosine kinase 2 and Janus kinase (JAK)1 previously administered orally in trials of other inflammatory dermatoses. In this issue of the BJD, Landis and coauthors report the…
read more here.
Keywords:
mild moderate;
brepocitinib;
brepocitinib cream;
moderate eczema ... See more keywords